Vijaya Dudyala, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 3 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
7 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dudyala’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
California Medical Board record
Licence A79466 · Current
Licensed to practise in California · since 2002 · expires 2028-05-31 · University of Health Sciences Vijayawada, Osmania Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$37,025
Medicare paid this office $37,025 for 130 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 77 | $12,605 | $105 |
| Long return visit (40+ min) | 31 | $7,513 | $153 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $4,345 | $161 |
| Short return visit (20+ min) | 46 | $4,059 | $72 |
| New patient visit (45+ min) | 15 | $2,074 | $138 |
See all 6 services
| Return visit (30+ min) | 77 | $12,605 | $105 |
| Long return visit (40+ min) | 31 | $7,513 | $153 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $4,345 | $161 |
| Short return visit (20+ min) | 46 | $4,059 | $72 |
| New patient visit (45+ min) | 15 | $2,074 | $138 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 69 | $1,529 | $14 |
Who their Medicare patients are
130 Original Medicare patients in 2024. Average age 76 · Women 75% · Also on Medicaid 12% · Health risk score 1.12. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 27% · Chronic kidney disease 20% · Coronary heart disease 19% · Cancer 18% · Depression 18% · Atrial fibrillation 13% · COPD 12% · Heart failure 9%.
The office billed $149,517, Medicare allowed $51,071 and paid $37,025; for 439 services of 27 kinds; $1,694 of it was for drugs given in the office and $35,331 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 130 | 439 | 76 | 1.12 | $149,517 | $37,025 |
| 2023 | 67 | 118 | 76 | 1.26 | $53,701 | $11,322 |
| 2022 | 115 | 343 | 74 | 1.15 | $143,322 | $34,880 |
| 2021 | 219 | 584 | 75 | 1.13 | $174,382 | $48,002 |
| 2020 | 119 | 357 | 76 | 1.02 | $91,393 | $23,885 |
| 2019 | 101 | 268 | 76 | 1.07 | $74,889 | $19,426 |
| 2018 | 85 | 158 | 76 | 1.10 | $35,094 | $9,105 |
| 2017 | 106 | 518 | 73 | 1.34 | $62,169 | $21,885 |
| 2016 | 54 | 150 | 72 | 1.22 | $25,627 | $9,922 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 50 | $5,327 | $85 |
| Long return visit (40+ min) | 14 | $2,393 | $141 |
2022: 7 services
| Return visit (30+ min) | 79 | $15,118 | $101 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $6,581 | $161 |
| Long return visit (40+ min) | 18 | $3,419 | $171 |
| New patient visit (45+ min) | 25 | $2,514 | $101 |
| Short return visit (20+ min) | 20 | $1,860 | $77 |
| Influenza vaccine split virus, preservative free | 16 | $1,097 | $69 |
| Administration of influenza virus vaccine | 17 | $645 | $38 |
2021: 11 services
| Return visit (30+ min) | 100 | $15,774 | $106 |
| Short return visit (20+ min) | 88 | $8,905 | $75 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $4,876 | $163 |
| Telephone medical discussion with physician, 21-30 minutes | 43 | $3,922 | $77 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $2,833 | $69 |
| New patient visit (45+ min) | 22 | $1,948 | $89 |
| Influenza vaccine split virus, preservative free | 22 | $1,436 | $65 |
| New patient visit (30+ min) | 18 | $1,388 | $77 |
| Short return visit | 14 | $711 | $51 |
| Administration of influenza virus vaccine | 24 | $522 | $22 |
| Urinalysis, manual test | 15 | $56 | $3 |
2020: 9 services
| Return visit (30+ min) | 52 | $6,363 | $80 |
| Short return visit (20+ min) | 42 | $3,358 | $54 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,478 | $89 |
| New patient visit (45+ min) | 16 | $1,990 | $124 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,847 | $142 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,289 | $61 |
| Administration of pneumococcal vaccine | 11 | $209 | $19 |
| Insertion of needle into vein for collection of blood sample | 23 | $96 | $3 |
| Urinalysis, manual test | 14 | $59 | $3 |
2019: 3 services
| Return visit (30+ min) | 41 | $6,855 | $93 |
| Short return visit (20+ min) | 65 | $5,614 | $63 |
| New patient visit (45+ min) | 17 | $2,351 | $138 |
2018: 2 services
| Short return visit (20+ min) | 55 | $3,795 | $54 |
| Return visit (30+ min) | 31 | $2,971 | $69 |
2017: 6 services
| Return visit (30+ min) | 54 | $8,116 | $75 |
| Short return visit (20+ min) | 51 | $4,049 | $57 |
| Influenza vaccine, inactivated | 15 | $738 | $49 |
| New patient visit (45+ min) | 11 | $700 | $64 |
| Administration of influenza virus vaccine | 19 | $591 | $31 |
| Injection of drug or substance under skin or into muscle | 13 | $298 | $23 |
2016: 4 services
| Return visit (30+ min) | 26 | $3,253 | $83 |
| Short return visit (20+ min) | 30 | $2,475 | $59 |
| Influenza vaccine, inactivated | 11 | $403 | $37 |
| Administration of influenza virus vaccine | 12 | $359 | $30 |
Medicaid work
$2,145 in 2018
Medicaid paid $2,145 for 29 billed services this clinician did in 2018, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 16 | $1,359 |
| Short return visit (20+ min) | 13 | $785 |
| 2018 | 29 | 2 | 14 | $2,145 |
Drugs they prescribed that Part D paid
$130,787
Pharmacies billed $130,787 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (24 of 1,450) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,266 generic and fewer than 11 brand-name prescriptions · $130,787 in drug cost · 45 antibiotic prescriptions to 35 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 16 | $22,899 | $1,431 |
| Farxiga | 12 | $18,500 | $1,542 |
| Januvia | 14 | $14,171 | $1,012 |
| Arnuity Ellipta | 11 | $2,172 | $197 |
| Rosuvastatin | 58 | $1,424 | $25 |
See all 35 drugs
| Jardiance | 16 | $22,899 | $1,431 |
| Farxiga | 12 | $18,500 | $1,542 |
| Januvia | 14 | $14,171 | $1,012 |
| Arnuity Ellipta | 11 | $2,172 | $197 |
| Rosuvastatin | 58 | $1,424 | $25 |
| Levothyroxine | 80 | $1,248 | $16 |
| Atorvastatin | 121 | $691 | $6 |
| Olmesartan Medoxomil | 28 | $669 | $24 |
| Amlodipine Besylate | 89 | $535 | $6 |
| Gabapentin | 37 | $499 | $13 |
| Omeprazole | 17 | $425 | $25 |
| Metformin | 48 | $422 | $9 |
| Losartan | 53 | $380 | $7 |
| Lisinopril | 46 | $376 | $8 |
| Pravastatin | 11 | $367 | $33 |
| Celecoxib | 15 | $362 | $24 |
| Pilocarpine | 15 | $325 | $22 |
| Metoprolol | 32 | $266 | $8 |
| Metformin Hcl Er | 17 | $254 | $15 |
| Pantoprazole | 24 | $254 | $11 |
| Simvastatin | 25 | $244 | $10 |
| Zolpidem | 13 | $235 | $18 |
| Hydrocodone-Acetaminophen | 20 | $218 | $11 |
| Losartan-Hydrochlorothiazide | 13 | $216 | $17 |
| Hydrochlorothiazide | 32 | $184 | $6 |
| Trazodone | 18 | $144 | $8 |
| Atenolol | 16 | $131 | $8 |
| Alendronate | 22 | $119 | $5 |
| Metoprolol | 15 | $111 | $7 |
| Fluticasone Propionate | 11 | $109 | $10 |
| Sertraline | 13 | $98 | $8 |
| Pioglitazone | 14 | $95 | $7 |
| Nitrofurantoin Mono-Macro | 14 | $81 | $6 |
| Tamsulosin | 18 | $78 | $4 |
| Azithromycin | 12 | $45 | $4 |
Year by year
| 2024 | 1,450 | 204 | 2% (24) | None | $130,787 |
| 2023 | 963 | 125 | 1% (12) | None | $76,056 |
| 2022 | 1,272 | 147 | 1% (12) | None | $75,979 |
| 2021 | 952 | 137 | 1% (11) | 11% | $43,936 |
| 2020 | 811 | 107 | 2% (18) | 14% | $48,357 |
| 2019 | 435 | 91 | 5% (22) | None | $33,588 |
| 2018 | 294 | 90 | None | 16% | $17,260 |
| 2017 | 691 | 84 | 3% (23) | 16% | $36,984 |
| 2016 | 354 | 59 | 3% (12) | 16% | $13,624 |
| 2015 | 275 | 52 | None | 44% | $21,383 |
| 2014 | 201 | 51 | None | 16% | $8,072 |
| 2013 | 44 | 21 | 0% (0) | 30% | $1,839 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Lantus Solostar | 15 | $8,340 | $556 |
| Rosuvastatin | 29 | $1,741 | $60 |
| Levothyroxine | 66 | $1,290 | $20 |
| Atorvastatin | 96 | $1,262 | $13 |
| Amlodipine Besylate | 71 | $1,184 | $17 |
| Losartan | 42 | $648 | $15 |
| Donepezil | 13 | $378 | $29 |
| Lisinopril | 44 | $363 | $8 |
| Albuterol Sulfate Hfa | 11 | $356 | $32 |
| Metoprolol | 20 | $352 | $18 |
| Gabapentin | 22 | $349 | $16 |
| Metformin | 26 | $346 | $13 |
| Atenolol | 19 | $330 | $17 |
| Alendronate | 15 | $325 | $22 |
| Simvastatin | 27 | $313 | $12 |
| Metoprolol | 15 | $265 | $18 |
| Omeprazole | 12 | $219 | $18 |
| Hydrochlorothiazide | 24 | $180 | $7 |
| Glipizide | 14 | $110 | $8 |
2022: 28 drugs
| Farxiga | 11 | $13,580 | $1,235 |
| Levothyroxine | 98 | $2,093 | $21 |
| Atorvastatin | 111 | $1,654 | $15 |
| Rosuvastatin | 20 | $1,121 | $56 |
| Amlodipine Besylate | 89 | $1,003 | $11 |
| Olmesartan Medoxomil | 18 | $670 | $37 |
| Metoprolol | 35 | $656 | $19 |
| Lisinopril | 74 | $632 | $9 |
| Albuterol Sulfate Hfa | 15 | $540 | $36 |
| Losartan | 39 | $522 | $13 |
| Simvastatin | 36 | $512 | $14 |
| Metformin | 40 | $416 | $10 |
| Hydrochlorothiazide | 40 | $403 | $10 |
| Sertraline | 20 | $313 | $16 |
| Metoprolol | 19 | $306 | $16 |
| Gabapentin | 27 | $298 | $11 |
| Metformin Hcl Er | 17 | $271 | $16 |
| Donepezil | 14 | $261 | $19 |
| Tamsulosin | 12 | $218 | $18 |
| Alendronate | 13 | $216 | $17 |
| Trazodone | 13 | $204 | $16 |
| Atenolol | 25 | $183 | $7 |
| Omeprazole | 19 | $175 | $9 |
| Pantoprazole | 17 | $167 | $10 |
| Fluticasone Propionate | 11 | $144 | $13 |
| Glipizide | 19 | $133 | $7 |
| Lorazepam | 23 | $118 | $5 |
| Lactulose | 11 | $90 | $8 |
2021: 22 drugs
| Levothyroxine | 84 | $1,841 | $22 |
| Rosuvastatin | 16 | $1,052 | $66 |
| Atorvastatin | 57 | $894 | $16 |
| Albuterol Sulfate Hfa | 21 | $740 | $35 |
| Metformin | 46 | $675 | $15 |
| Lisinopril | 79 | $614 | $8 |
| Losartan | 32 | $560 | $18 |
| Amlodipine Besylate | 49 | $554 | $11 |
| Metoprolol | 23 | $450 | $20 |
| Simvastatin | 24 | $260 | $11 |
| Donepezil | 19 | $205 | $11 |
| Gabapentin | 20 | $192 | $10 |
| Hydrochlorothiazide | 22 | $186 | $8 |
| Sertraline | 13 | $177 | $14 |
| Citalopram Hbr | 12 | $154 | $13 |
| Glipizide | 16 | $152 | $9 |
| Metformin Hcl Er | 12 | $149 | $12 |
| Montelukast | 15 | $133 | $9 |
| Nortriptyline | 11 | $128 | $12 |
| Atenolol | 13 | $80 | $6 |
| Furosemide | 11 | $53 | $5 |
| Omeprazole | 13 | $47 | $4 |
2020: 20 drugs
| Levothyroxine | 64 | $1,727 | $27 |
| Acyclovir | 13 | $1,553 | $119 |
| Atorvastatin | 40 | $761 | $19 |
| Lisinopril | 47 | $345 | $7 |
| Sertraline | 13 | $304 | $23 |
| Metformin | 23 | $277 | $12 |
| Losartan | 15 | $264 | $18 |
| Amlodipine Besylate | 36 | $258 | $7 |
| Alendronate | 19 | $248 | $13 |
| Glimepiride | 11 | $202 | $18 |
| Pantoprazole | 12 | $165 | $14 |
| Simvastatin | 17 | $164 | $10 |
| Gabapentin | 12 | $157 | $13 |
| Hydrochlorothiazide | 18 | $147 | $8 |
| Omeprazole | 19 | $141 | $7 |
| Metoprolol | 12 | $104 | $9 |
| Donepezil | 12 | $93 | $8 |
| Atenolol | 18 | $78 | $4 |
| Alprazolam | 15 | $76 | $5 |
| Furosemide | 18 | $67 | $4 |
2019: 8 drugs
| Levothyroxine | 20 | $589 | $29 |
| Metoprolol | 12 | $332 | $28 |
| Lisinopril | 24 | $289 | $12 |
| Amlodipine Besylate | 13 | $224 | $17 |
| Omeprazole | 15 | $198 | $13 |
| Azithromycin | 12 | $110 | $9 |
| Furosemide | 11 | $41 | $4 |
| Tramadol | 14 | $41 | $3 |
2018: 5 drugs
| Levothyroxine | 20 | $457 | $23 |
| Atorvastatin | 16 | $328 | $21 |
| Metformin | 13 | $120 | $9 |
| Omeprazole | 15 | $109 | $7 |
| Furosemide | 11 | $57 | $5 |
2017: 18 drugs
| Lyrica | 17 | $17,110 | $1,006 |
| Levothyroxine | 42 | $836 | $20 |
| Atorvastatin | 38 | $653 | $17 |
| Metformin | 34 | $461 | $14 |
| Digoxin | 12 | $433 | $36 |
| Diltiazem | 11 | $398 | $36 |
| Losartan | 12 | $312 | $26 |
| Simvastatin | 19 | $275 | $14 |
| Hydrocodone-Acetaminophen | 21 | $221 | $11 |
| Furosemide | 41 | $215 | $5 |
| Glipizide | 21 | $185 | $9 |
| Donepezil | 14 | $180 | $13 |
| Potassium Chloride | 13 | $169 | $13 |
| Omeprazole | 29 | $166 | $6 |
| Lisinopril | 24 | $166 | $7 |
| Metoprolol | 12 | $164 | $14 |
| Amlodipine Besylate | 29 | $159 | $5 |
| Atenolol | 27 | $148 | $5 |
2016: 9 drugs
| Atorvastatin | 15 | $192 | $13 |
| Losartan | 11 | $186 | $17 |
| Levothyroxine | 15 | $185 | $12 |
| Lisinopril | 21 | $171 | $8 |
| Amlodipine Besylate | 30 | $163 | $5 |
| Atenolol | 18 | $160 | $9 |
| Metformin | 16 | $158 | $10 |
| Omeprazole | 15 | $139 | $9 |
| Furosemide | 25 | $114 | $5 |
2015: 5 drugs
| Zetia | 31 | $3,731 | $120 |
| Lidoderm | 12 | $3,718 | $310 |
| Myambutol | 12 | $636 | $53 |
| Furosemide | 34 | $214 | $6 |
| Pantoprazole | 19 | $213 | $11 |
2014: 2 drugs
| Levofloxacin | 11 | $127 | $12 |
| Lisinopril | 11 | $51 | $5 |
Money from drug and device companies
$789 in 2025
| 2025 | 7 | 7 | None | $789 |
| 2024 | 2 | 2 | None | $241 |
| 2023 | 2 | 3 | None | $63 |
| 2022 | 2 | 2 | None | $245 |
| 2020 | 1 | 1 | None | $18 |
| 2019 | 4 | 7 | None | $289 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Freestyle Libre 3 | $158 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $150 | 1 payment
|
| Lilly USA | Jardiance | $125 | 1 payment
|
| Novo Nordisk | Ozempic | $116 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | None | $116 | 1 payment
|
| Radius Health | Tymlos | $96 | 1 payment
|
See all 7 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-07 | Kerendia | $150 |
| Novo Nordisk | Meals · 2025-10-21 | Ozempic | $116 |
| Abbott Laboratories | Meals · 2025-07-22 | Freestyle Libre 3 | $158 |
| Radius Health | Meals · 2025-04-29 | Tymlos | $96 |
| Lilly USA | Meals · 2025-04-10 | Jardiance | $125 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-27 | None | $116 |
| Exact Sciences | Meals · 2025-03-23 | Cologuard Collection Kit | $27 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $241
| GlaxoSmithKline | Arexvy | $122 | 1 payment
|
| Novo Nordisk | None | $119 | 1 payment
|
2023: $63
| Exact Sciences | Cologuard Collection Kit | $45 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $17 | 1 payment
|
2022: $245
| AstraZeneca Pharmaceuticals LP | Farxiga | $125 | 1 payment
|
| Radius Health | Tymlos | $120 | 1 payment
|
2020: $18
| GlaxoSmithKline | Shingrix | $18 | 1 payment
|
2019: $289
| Lilly USA | Jardiance | $129 | 4 payments
|
| Boston Scientific | General Therapies | $110 | 1 payment
|
| Amgen | Evenity | $32 | 1 payment
|
| Relypsa | Veltassa | $19 | 1 payment
|
Professional record
- NPI
- 1477522589
- Licence
- CA A79466California A79466: Current · expires 2028-05-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A794660
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 828 S Winchester Blvd, San Jose, CA, 95128
- NPI first listed
- 2006-03-14
- NPI last updated
- 2020-11-11
- NPI record certified
- 2020-11-11
This is when the NPI record was last certified, not a medical board exam.